Surprisingly, as it was never seen before in other transgenic rat models of AD and even in transgenic AD mouse models expressing APP and PS1 mutations, by 16 months of age these rats present Gallyas-positive structures resembling NFTs seen in human AD. The gene discussed is PSEN1; the disease is Alzheimer disease.